Skin test concentrations for systemically administered drugs - An ENDA/EAACI Drug Allergy Interest Group position paper

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 6, 2013, Pages 702-712

  Brockow, K ^a   Garvey, L H ^b   Aberer, W ^c   Atanaskovic Markovic, M ^d   Barbaud, A ^e   Bilo, M B ^f   Bircher, A ^g   Blanca, M ^h   Bonadonna, B ⁱ   Campi, P ^j   Castro, E ^k   Cernadas, J R ^k   Chiriac, A M ^l   Demoly, P ^l   Grosber, M ^a   Gooi, J ^m   Lombardo, C ⁱ   Mertes, P M ⁿ   Mosbech, H ^b   Nasser, S ^o   Pagani, M ^p   Ring, J ^a   Romano, A ^q,u   Scherer, K ^g   Schnyder, B ^r   Testi, S ^j   Torres, M ^h   Trautmann, A ^s   Terreehorst, I ^t   more..

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

^e UNIVERSITÉ DE LORRAINE   (France)

^f OSPEDALI RIUNITI   (Italy)

^g Universitatsspital Basel Dermatologie   (Switzerland)

^h HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

ⁱ UNIVERSITY HOSPITAL OF VERONA   (Italy)

^j SAN GIOVANNI DI DIO HOSPITAL   (Italy)

^k Unit of Reproductive Medicine Department of Gynecology Hospital Centre of S John Porto   (Portugal)

^l MONTPELLIER UNIVERSITY HOSPITAL   (France)

^m BEAUMONT HOSPITAL   (Ireland)

ⁿ UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^o ADDENBROOKE S HOSPITAL   (United Kingdom)

^p Asola Hospital   (Italy)

^q Allergy Unit   (Italy)

^r Department of Rheumatology Clinical Immunology and Allergology ^*  (Switzerland)

^s UNIVERSITY OF WÜRZBURG   (Germany)

^t ACADEMIC MEDICAL CENTER   (Netherlands)

^u OASI RESEARCH INSTITUTE IRCCS   (Italy)

more..

Author keywords

diagnosis; drug allergy; drug hypersensitivity; intradermal test; skin test

Indexed keywords

ABACAVIR; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT; CARBAMAZEPINE; CEPHALOSPORIN; CODEINE; DYE; GADOLINIUM CHELATE; HEPARIN; HEPARINOID; HORMONES AND HORMONE ANALOGS; IMMUNOGLOBULIN; IODINATED CONTRAST MEDIUM; LOCAL ANESTHETIC AGENT; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PENICILLIN DERIVATIVE; PETHIDINE; PHARMACEUTICAL VEHICLES AND ADDITIVES; PHENYTOIN; PROTON PUMP INHIBITOR; TRAMADOL; UNINDEXED DRUG; VACCINE;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ARACHIDONIC ACID METABOLISM; ARTICLE; BRONCHOSPASM; DRUG HYPERSENSITIVITY; ECZEMA; HISTAMINE RELEASE; HUMAN; HYPOTENSION; IMMEDIATE TYPE HYPERSENSITIVITY; MACULOPAPULAR RASH; PATCH TEST; PENICILLIN ALLERGY; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; RASH; SKIN PENETRATION; SKIN TEST; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; URTICARIA;

DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; SENSITIVITY AND SPECIFICITY; SKIN TESTS;

EID: 84876813953     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12142     Document Type: Article

References (65)

1. Gomes ER, Demoly P,. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005; 5: 309-316.
2. Brockow K, Romano A, Blanca M, et al. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45-51.
3. Brockow K, Romano A,. Skin tests in the diagnosis of drug hypersensitivity reactions. Curr Pharm Des 2008; 14: 2778-2791.
4. Demoly P, Kropf R, Bircher A, Pichler WJ,. Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity. Allergy 1999; 54: 999-1003.
5. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58: 854-863.
6. Blanca M, Romano A, Torres MJ, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009; 64: 183-193.
7. Mertes PM, Malinovsky JM, Jouffroy L, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 2011; 21: 442-453.
8. Brockow K, Christiansen C, Kanny G, et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005; 60: 150-158.
9. Kowalski ML, Makowska JS, Blanca M, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)-classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA. Allergy 2011; 66: 818-829.
10. Cernadas JR, Brockow K, Romano A, et al. General considerations on rapid desensitization for drug hypersensitivity-a consensus statement. Allergy 2010; 65: 1357-1366.
11. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490.
12. Barbaud A, Goncalo M, Bruynzeel D, Bircher A,. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 321-328.
13. Barbaud A, Trechot P, Reichert-Penetrat S, Commun N, Schmutz JL., Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 265-268.
14. Testi S, Severino M, Iorno ML, et al. Nonirritating concentration for skin testing with cephalosporins. J Investig Allergol Clin Immunol 2010; 20: 171-172.
15. Romano A, Gaeta F, Valluzzi RL, et al. Diagnosing nonimmediate reactions to cephalosporins. J Allergy Clin Immunol 2012; 129: 1166-1169.
16. Gomes E, Cardoso MF, Praca F, Gomes L, Marino E, Demoly P., Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy 2004; 34: 1597-1601.
17. Torres MJ, Ariza A, Fernandez J, et al. Role of minor determinants of amoxicillin in the diagnosis of immediate allergic reactions to amoxicillin. Allergy 2010; 65: 590-596.
18. Blanca M, Romano A, Torres MJ, Demoly P, DeWeck A., Continued need of appropriate betalactam-derived skin test reagents for the management of allergy to betalactams. Clin Exp Allergy 2007; 37: 166-173.
19. Lin E, Saxon A, Riedl M,. Penicillin allergy: value of including amoxicillin as a determinant in penicillin skin testing. Int Arch Allergy Immunol 2010; 152: 313-318.
20. Torres MJ, Ariza A, Mayorga C, et al. Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J Allergy Clin Immunol 2010; 125: 502-505.
21. Padial A, Antunez C, Blanca-Lopez N, et al. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 2008; 38: 822-828.
22. Torres MJ, Romano A, Mayorga C, et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 2001; 56: 850-856.
23. Bousquet PJ, Pipet A, Bousquet-Rouanet L, Demoly P,. Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy 2008; 38: 185-190.
24. Seitz CS, Brocker EB, Trautmann A,. Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clin Exp Allergy 2009; 39: 1738-1745.
25. Schmid DA, Campi P, Pichler WJ,. Hypersensitivity reactions to quinolones. Curr Pharm Des 2006; 12: 3313-3326.
26. Gonzalez I, Lobera T, Blasco A, del Pozo MD,. Immediate hypersensitivity to quinolones: moxifloxacin cross-reactivity. J Investig Allergol Clin Immunol 2005; 15: 146-149.
27. Empedrad R, Darter AL, Earl HS, Gruchalla RS,. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 2003; 112: 629-630.
28. Gomez E, Blanca-Lopez N, Torres MJ, et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy 2009; 39: 1217-1224.
29. Macias E, Ruiz A, Moreno E, Laffond E, Davila I, Lorente F., Usefulness of intradermal test and patch test in the diagnosis of nonimmediate reactions to metamizol. Allergy 2007; 62: 1462-1464.
30. Kleinhans M, Linzbach L, Zedlitz S, Kaufmann R, Boehncke WH., Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation. Contact Dermatitis 2002; 47: 100-102.
31. Nasser SM, Ewan PW,. Opiate-sensitivity: clinical characteristics and the role of skin prick testing. Clin Exp Allergy 2001; 31: 1014-1020.
32. Hogen Esch AJ, van der Heide S, van den Brink W, van Ree JM, Bruynzeel DP, Coenraads PJ., Contact allergy and respiratory/mucosal complaints from heroin (diacetylmorphine). Contact Dermatitis 2006; 54: 42-49.
33. Rodriguez F, Fernandez L, Garcia-Abujeta JL, Maquiera E, Llaca HF, Jerez J., Generalized dermatitis due to codeine. Contact Dermatitis 1995; 32: 120.
34. Mertes PM, Alla F, Trechot P, et al. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 2011; 128: 366-373.
35. Florvaag E, Johansson SG, Irgens A, de Pater GH,. IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market. Allergy 2011; 66: 955-960.
36. Mertes PM, Lambert M, Gueant-Rodriguez RM, et al. Perioperative anaphylaxis. Immunol Allergy Clin North Am 2009; 29: 429-451.
37. Garvey LH, Roed-Petersen J, Menne T, Husum B,. Danish anaesthesia allergy centre-preliminary results. Acta Anaesthesiol Scand 2001; 45: 1204-1209.
38. Garvey LH, Kroigaard M, Poulsen LK, et al. IgE-mediated allergy to chlorhexidine. J Allergy Clin Immunol 2007; 120: 409-415.
39. Gall H, Kaufmann R, Kalveram CM,. Adverse reactions to local anesthetics: analysis of 197 cases. J Allergy Clin Immunol 1996; 97: 933-937.
40. deShazo RD, Nelson HS,. An approach to the patient with a history of local anesthetic hypersensitivity: experience with 90 patients. J Allergy Clin Immunol 1979; 63: 387-394.
41. Bircher AJ, Harr T, Hohenstein L, Tsakiris DA,. Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options. Allergy 2006; 61: 1432-1440.
42. Horrow JC, Pharo GH, Levit LS, Freeland C,. Neither skin tests nor serum enzyme-linked immunosorbent assay tests provide specificity for protamine allergy. Anesth Analg 1996; 82: 386-389.
43. Vernassiere C, Trechot P, Commun N, Schmutz JL, Barbaud A., Low negative predictive value of skin tests in investigating delayed reactions to radio-contrast media. Contact Dermatitis 2004; 50: 359-366.
44. Galera C, Pur Ozygit L, Cavigioli S, Bousquet PJ, Demoly P., Gadoteridol-induced anaphylaxis-not a class allergy. Allergy 2010; 65: 132-134.
45. Mertes PM, Malinovsky JM, Mouton-Faivre C, et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J Allergy Clin Immunol 2008; 122: 348-352.
46. Knowles SR, Weber EA, Berbrayer CS,. Allergic reaction to fluorescein dye: successful one-day desensitization. Can J Ophthalmol 2007; 42: 329-330.
47. Seitz CS, Pfeuffer P, Raith P, Brocker EB, Trautmann A., Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents. Ann Allergy Asthma Immunol 2006; 97: 698-702.
48. Pichler WJ, Daubner B, Kawabata T,. Drug hypersensitivity: flare-up reactions, cross-reactivity and multiple drug hypersensitivity. J Dermatol 2011; 38: 216-221.
49. Phillips EJ, Sullivan JR, Knowles SR, Shear NH,. Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir. AIDS 2002; 16: 2223-2225.
50. Leguy-Seguin V, Jolimoy G, Coudert B, et al. Diagnostic and predictive value of skin testing in platinum salt hypersensitivity. J Allergy Clin Immunol 2007; 119: 726-730.
51. Benucci M, Manfredi M, Demoly P, Campi P,. Injection site reactions to TNF-alpha blocking agents with positive skin tests. Allergy 2008; 63: 138-139.
52. Vultaggio A, Matucci A, Nencini F, et al. Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions. Allergy 2010; 65: 657-661.
53. Lieberman P, Rahmaoui A, Wong DA,. The safety and interpretability of skin tests with omalizumab. Ann Allergy Asthma Immunol 2010; 105: 493-495.
54. Baeck M, Chemelle JA, Terreux R, Drieghe J, Goossens A., Delayed hypersensitivity to corticosteroids in a series of 315 patients: clinical data and patch test results. Contact Dermatitis 2009; 61: 163-175.
55. Isaksson M, Bruze M, Goossens A, Lepoittevin JP,. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time. Contact Dermatitis 1999; 40: 24-31.
56. Venturini M, Lobera T, del Pozo MD, Gonzalez I, Blasco A., Immediate hypersensitivity to corticosteroids. J Investig Allergol Clin Immunol 2006; 16: 51-56.
57. Heinzerling L, Raile K, Rochlitz H, Zuberbier T, Worm M., Insulin allergy: clinical manifestations and management strategies. Allergy 2008; 63: 148-155.
58. Wood RA, Berger M, Dreskin SC, et al. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics 2008; 122: e771-e777.
59. Wood RA, Setse R, Halsey N,. Irritant skin test reactions to common vaccines. J Allergy Clin Immunol 2007; 120: 478-481.
60. Barbaud A, Waton J, Pinault AL, Bursztejn AC, Schmutz JL, Trechot P., Cutaneous adverse drug reactions caused by delayed sensitization to carboxymethylcellulose. Contact Dermatitis 2011; 64: 294-297.
61. Dewachter P, Mouton-Faivre C,. Anaphylaxis to macrogol 4000 after a parenteral corticoid injection. Allergy 2005; 60: 705-706.
62. Vincent D, Ben Naoum Y, Chi HC, Hentschel V, Pradalier A., Systemic anaphylaxis induced by intradermal testing. Allerg Immunol (Paris) 2002; 34: 45-46.
63. Bonadonna P, Lombardo C, Bortolami O, et al. Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test. J Allergy Clin Immunol 2012; 130: 547-549.
64. Riezzo I, Bello S, Neri M, Turillazzi E, Fineschi V., Ceftriaxone intradermal test-related fatal anaphylactic shock: a medico-legal nightmare. Allergy 2010; 65: 130-131.
65. Gomes E, Pichler W, Demoly P, Aberer W, Frew A, deWeck A., The drug ambassador project: the diversity of diagnostic procedures for drug allergy around Europe. J World Allergy Org 2004; 17: 1-10.